Climb Bio, Inc. financial data

Symbol
CLYM on Nasdaq
Location
20 William Street, Suite 145, Wellesley Hills, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.87K % -62.3%
Debt-to-equity 3.2 % +61.5%
Return On Equity -26.4 % +37.4%
Return On Assets -25.6 % +38.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.2M shares +1.43%
Common Stock, Shares, Outstanding 68.2M shares +1.43%
Entity Public Float 196M USD +1384%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 68M shares +1.48%
Weighted Average Number of Shares Outstanding, Diluted 68M shares +1.48%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 38.8M USD +237%
General and Administrative Expense 20.6M USD +57.4%
Operating Income (Loss) -59.5M USD +22%
Nonoperating Income (Expense) 2M USD -29.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -50.8M USD +26.6%
Earnings Per Share, Basic 0 USD/shares +92.5%
Earnings Per Share, Diluted 0 USD/shares +92.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25.8M USD -82.3%
Marketable Securities, Current 61.1M USD +29.5%
Assets, Current 91M USD -54%
Property, Plant and Equipment, Net 318K USD
Operating Lease, Right-of-Use Asset 562K USD +4583%
Other Assets, Noncurrent 1.53M USD
Assets 182M USD -18%
Accounts Payable, Current 477K USD +63.9%
Employee-related Liabilities, Current 1.54M USD
Accrued Liabilities, Current 6.1M USD +131%
Liabilities, Current 4.95M USD +44.6%
Operating Lease, Liability, Noncurrent 352K USD
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 5.3M USD +54.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 469K USD +133%
Retained Earnings (Accumulated Deficit) -272M USD -22.9%
Stockholders' Equity Attributable to Parent 177M USD -19.1%
Liabilities and Equity 182M USD -18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.4M USD -748%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -42.8M USD -411%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 68.2M shares +1.43%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -58.2M USD -588%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 25.8M USD -82.3%
Deferred Tax Assets, Valuation Allowance 28.5M USD +36.6%
Deferred Tax Assets, Gross 28.6M USD +37.2%
Operating Lease, Liability 585K USD -15.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -50.5M USD +26.7%
Lessee, Operating Lease, Liability, to be Paid 611K USD -17.8%
Operating Lease, Liability, Current 228K USD +293%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15K USD -95.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 342K USD +45.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +13.3%
Deferred Tax Assets, Operating Loss Carryforwards 22.7M USD +32.6%
Share-based Payment Arrangement, Expense 8.67M USD +69.9%